Skip to content

Health Outcomes and Costs (HOC) in Lung Cancer (LC)

Health Outcomes and Costs (HOC) in Brazilian Public Health Care System - The HOC Study in Lung Cancer

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02363101
Acronym
HOC-LC
Enrollment
300
Registered
2015-02-13
Start date
2015-03-31
Completion date
2016-12-31
Last updated
2015-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Brief summary

The purpose of this study is to evaluate the costs, health-related quality of life and preference values from lung cancer patients assisted in a Brazilian public health care unit.

Detailed description

The costs will be assessed by micro-costing approach. All procedures involved in lung cancer at diagnosis, staging, treatment and best supportive care will be assessed. The health-related quality of life will be assessed by EORTC-QLQ-C30, EQ-5D and EORTC-QLQ-LC13 in all different stages of lung cancer. An utility measure will be considered. The preference values will be assessed via discrete choice experiment. Two scenarios will be designed and the lung cancer patients will be asked about the preferences.

Interventions

None listed

Sponsors

Instituto Nacional de Cardiologia de Laranjeiras
CollaboratorOTHER
Instituto Nacional de Cancer, Brazil
Lead SponsorOTHER_GOV

Study design

Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Clinical diagnosis of lung cancer disease * Able to understand the overall concept of study and sign the written informed consent

Exclusion criteria

* Illiterate * Visible cognitive impaired * Non-primary lung tumor

Design outcomes

Primary

MeasureTime frameDescription
Direct costsone yearDirect costs related to each procedure involved on lung cancer
HRQoLup to 30 days after the procedure
Preference valuescross sectionalEvaluate preference values in hypothetic scenarios

Countries

Brazil

Contacts

Primary ContactLuciene Schluckebier
lschluckebier@inca.gov.br552132076660
Backup ContactAlessandra Marins
amarins@inca.gov.br55 21 32076569

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026